Clinical trials test the safety and efficacy of new treatments for infectious and chronic diseases. Learn how these studies work and how you can participate in this necessary research.
The COVID-19 pandemic and widespread development of Long COVID have done much to highlight the importance of clinical research studies in developing not only vaccines but also safe, effective treatments for infectious diseases and chronic conditions. Long COVID sufferers in the U.S. are understandably frustrated by the slow progress of relevant clinical trials.
Unfortunately, one of the biggest barriers to progress is the low rate of enrollment. If there aren’t enough participants to start the study, or to provide enough significant data, the study doesn’t happen, and the money that went into setting it up is wasted. Here is some basic information about what clinical trials are, how they work, and what it means to participate in one.*
Clinical trials help doctors and scientists learn about experimental drugs and other therapeutic devices, including how well they work and how safe they are for human use. Clinical trials may study the study drug by itself or compare it to either an approved medication or a placebo.
Clinical trials play a vital role in discovering new, viable treatment options for both acute and chronic diseases. In the United States, all new medications must undergo multiple phases of research before they can be evaluated by the Food and Drug Administration.
Before enrolling you in a clinical trial, the trial doctor will provide you with a packet of information about that trial, as well as an ‘informed consent’ form. Every clinical trial is different, so it is important to always read all the information that is provided and ask questions about anything you don’t understand before signing the form.
Prospective participants will always be informed of the procedures that they can expect to undergo before they decide to join the clinical trial. Participation in a clinical trial is broken down into three separate stages: Screening, Study Treatment, and Follow-up.
The purpose of the screening period is to make sure participants are a good match for the trial.
During the screening stage of most clinical trials, you can expect to:
Some trials have lengthy screening periods involving multiple medical tests before you’re even deemed eligible to join the study, so be prepared for varying time commitments.
If you are deemed eligible to participate in the trial, the trial doctor will officially enroll you and give you the study drug, along with instructions on how to take it once you’re at home.
During the treatment phase of the clinical trial, you will be expected to:
Participants are also expected to inform the trial doctor of any changes in health, including new or worsening medical conditions, and any changes in medications while taking the study drug.
Participants will usually complete one last visit after they are done with the study drug, though some studies require months or years of follow-up with participants, whether through physical exams, phone calls, questionnaires, or a combination of the three.
You do not have to pay or have health insurance to sign up for a clinical trial. The trial drug and trial-related procedures are provided to participants at no charge to participants or their health insurance companies. Clinical trials often compensate participants for their time and effort.
Participating in a clinical trial is always voluntary. Even after signing up, you can leave at any point during the screening or trial process.
*Learn About Clinical Studies. National Institutes of Health, U.S. National Library of Medicine. Retrieved from https://clinicaltrials.gov/ct2/about-studies/learn
Source: {{articlecontent.article.sourceName}}
Receive daily updated expert-reviewed article summaries. Everything you need to know from discoveries, treatments, and living tips!
Already a Responsum member?
Available for Apple iOS and Android
Add Comments
Cancel